Source comparison
Melanotan-1 Help Tanning Research: Dosing Protocols Comparison
Photoprotection studies 0.16 mg/kg subcutaneous every other day × 10 doses 7–10 days Eumelanin optical density vs UVB minimal erythema dose correlation Isolates melanin's UV-absorptive capacity from inflammatory photoprotection—enables quantification of melani
This comparison does not assign a generated winner or score.
- Photoprotection studies
- 0.16 mg/kg subcutaneous every other day × 10 doses
- 7–10 days
- Eumelanin optical density vs UVB minimal erythema dose correlation
- Isolates melanin's UV-absorptive capacity from inflammatory photoprotection—enables quantification of melanin-specific shielding
- Melanoma chemoprevention models
- 100 µg/day subcutaneous × 5 days (murine models)
- 48–72 hours
- MC1R activation in MC1R-deficient genotypes; DNA damage reduction
- Proves that exogenous MC1R agonism can restore eumelanin synthesis in redheads—critical for identifying at-risk populations who could benefit from prophylactic pigmentation
- EPP clinical trials (FDA-approved)
- 16 mg subcutaneous implant (Scenesse) every 60 days
- 5–7 days
- Constitutive pigmentation without UV trigger
- Only photoprotection method safe for patients where UV itself is contraindicated—extends pain-free daylight exposure by 69% (JAMA Dermatology 2015)
- Melanocyte signaling pathway studies
- 1 µM in vitro melanocyte cultures
- N/A (intracellular cAMP elevation within 10 minutes)
- cAMP → CREB → MITF → tyrosinase transcriptional cascade
- Allows dissection of melanogenic signaling independent of keratinocyte paracrine factors—reveals intrinsic melanocyte responses vs microenvironment-driven responses